Zimbabwe has rejected a significant US health deal worth 367 million US dollars (£272m) spanning five years because of Washington's insistence on confidential biological samples.
This rejection became public after a official document dated December was leaked, which showed President Emmerson Mnangagwa felt the arrangement was "skewed".
An official spokesperson has since explained that the United States was requesting genetic material for research and commercial purposes while refused to share the benefits from any future treatments.
"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged more dialogue to reach a deal acceptable to both sides so the country's critical HIV programme can continue.
Wider Context
This development follows a similar case in Kenya, where a court blocked a related deal with the US following legal challenges were raised about the security of Kenyans' health data.
Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump claimed its spending was "inefficient" and his administration was pursuing government-to-government agreements to boost transparency and responsibility.
As per reports, Sixteen African countries have to date signed these new health pacts, constituting over $18.3bn of fresh investment.
Details of the Rejected Agreement
The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment via American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, with no corresponding assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Put simply, our country would provide the basic resources for medical research without any certainty that the final treatments would be accessible to our population if a future health crisis emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting frameworks previously established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.
"This mechanism is intended to guarantee that when a country provides its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome ongoing discussions with our American counterparts on how subsequent co-operation could be arranged in a way that honours the sovereignty and interests of each country."
Medical Community Response
Medical experts said it recognised the government's concerns, but suggested that talks should continue since much of the nation's Aids initiatives depended on external financing.
"If specific concerns exist, including those relating to data governance or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it added.
This impasse underscores the ongoing challenges between accepting vital international aid and safeguarding national sovereignty in an ever more interconnected world.